Works matching IS 17762596 AND DT 2023 AND VI 18 AND IP 3

Results: 13

HER2-Low Breast Cancer—Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast.

Published in:

2023

By:

Bardia, Aditya;
Viale, Giuseppe

Publication type:

Letter

P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2− Metastatic Breast Cancer—A Podcast.

Published in:

2023

By:

Brufsky, Adam;
Gallagher, Christopher

Publication type:

Letter

A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 383, doi. 10.1007/s11523-023-00967-5

By:

De La Cerda, Jose;
Dunshee, Curtis;
Gervasi, Lawrence;
Sieber, Paul;
Belkoff, Laurence;
Tutrone, Ronald;
Lu, Sophia;
Gatoulis, Sergio C.;
Brown, Bruce;
Migoya, Elizabeth;
Shore, Neal

Publication type:

Article

Uncovering the Burden of Immune-Related Adverse Events in Immunotherapy: Insights from a Nationally Representative Sample.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 451, doi. 10.1007/s11523-023-00969-3

By:

Pichardo, Rayli;
Abu Omar, Yazan;
Wani, Kashmira;
Shango, Kathren;
Wang, Ding

Publication type:

Article

Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 463, doi. 10.1007/s11523-023-00971-9

By:

Nie, Tina;
Blair, Hannah A.

Publication type:

Article

A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 369, doi. 10.1007/s11523-023-00963-9

By:

Izawa, Naoki;
Masuishi, Toshiki;
Takahashi, Naoki;
Shoji, Hirokazu;
Yamamoto, Yoshiyuki;
Matsumoto, Toshihiko;
Sugiyama, Keiji;
Kajiwara, Takeshi;
Kawakami, Kentaro;
Aomatsu, Naoki;
Kondoh, Chihiro;
Kawakami, Hisato;
Takegawa, Naoki;
Esaki, Taito;
Shimokawa, Mototsugu;
Nishio, Kazuto;
Narita, Yukiya;
Hara, Hiroki;
Sunakawa, Yu;
Boku, Narikazu

Publication type:

Article

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 415, doi. 10.1007/s11523-023-00960-y

By:

Mohammadi, Mahmoud;
IJzerman, Nikki S.;
Hollander, Dide den;
Bleckman, Roos F.;
Oosten, Astrid W.;
Desar, Ingrid M. E.;
Reyners, An K. L.;
Steeghs, Neeltje;
Gelderblom, Hans

Publication type:

Article

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 391, doi. 10.1007/s11523-023-00962-w

By:

Chee, Cheng E.;
Ooi, Melissa;
Lee, Soo-Chin;
Sundar, Raghav;
Heong, Valerie;
Yong, Wei-Peng;
Ng, Chin Hin;
Wong, Andrea;
Lim, Joline S. J.;
Tan, David S. P.;
Soo, Ross;
Tan, Joshua T. C.;
Yang, Song;
Thura, Min;
Al-Aidaroos, Abdul Qader;
Chng, Wee Joo;
Zeng, Qi;
Goh, Boon-Cher

Publication type:

Article

A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 441, doi. 10.1007/s11523-023-00958-6

By:

ter Heine, Rob;
van den Heuvel, Michel M.;
Piet, Berber;
Deenen, Maarten J.;
van der Wekken, Anthonie J.;
Hendriks, Lizza E. L.;
Croes, Sander;
van Geel, Robin M. J. M.;
Jansman, Frank G. A.;
Boshuizen, Rogier C.;
Franssen, Eric J. F.;
Smit, Arthur A. J.;
Dumoulin, Daphne W.;
Oude Munnink, Thijs H.;
Smit, Egbert F.;
Derijks, Hieronymus J.;
van der Leest, Cor H.;
Hendrikx, Jeroen J. M. A.;
Moes, Dirk J. A. R.;
de Rouw, Nikki

Publication type:

Article

A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09).

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 359, doi. 10.1007/s11523-023-00961-x

By:

Kawabata, Ryohei;
Izawa, Naoki;
Suzuki, Takahisa;
Nagahisa, Yoshio;
Nishikawa, Kazuhiro;
Takahashi, Masazumi;
Nakamura, Masato;
Ishiguro, Atsushi;
Katsuya, Hiroo;
Hihara, Jun;
Manaka, Dai;
Negoro, Yuji;
Tsuji, Akihito;
Takahashi, Takao;
Kochi, Mitsugu;
Azuma, Mizutomo;
Kadowaki, Shigenori;
Michimae, Hirofumi;
Sunakawa, Yu;
Ichikawa, Wataru

Publication type:

Article

Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 403, doi. 10.1007/s11523-023-00959-5

By:

Williams, Steven C. R.;
Mazibuko, Ndaba;
O'Daly, Owen;
Zurth, Christian;
Patrick, Fiona;
Kappeler, Christian;
Kuss, Iris;
Cole, Patricia E.

Publication type:

Article

Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 327, doi. 10.1007/s11523-023-00957-7

By:

Zhao, Melody;
Hanson, Kent A.;
Zhang, Yixie;
Zhou, Anna;
Cha-Silva, Ashley S.

Publication type:

Article

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.

Published in:

Targeted Oncology, 2023, v. 18, n. 3, p. 425, doi. 10.1007/s11523-023-00955-9

By:

Chamorro, Diego F.;
Cardona, Andrés F.;
Rodríguez, July;
Ruiz-Patiño, Alejandro;
Arrieta, Oscar;
Moreno-Pérez, Darwin A.;
Rojas, Leonardo;
Zatarain-Barrón, Zyanya Lucia;
Ardila, Dora V.;
Viola, Lucia;
Recondo, Gonzalo;
Blaquier, Juan B.;
Martín, Claudio;
Raez, Luis;
Samtani, Suraj;
Ordóñez-Reyes, Camila;
Garcia-Robledo, Juan Esteban;
Corrales, Luis;
Sotelo, Carolina;
Ricaurte, Luisa

Publication type:

Article